The ratio of Resolvin D1 to pro-inflammatory chemokine IL-8 is low in sputum of CF patients, even in the absence of an acute infection or exacerbation, strongly suggesting that there is an important pathophysiological effect for Resolvin anti-inflammatory and pro- resolution activity in the CF lung. The gene discussed is CXCL8; the disease is cystic fibrosis.